Loopbaan van Carolyn Finkle
Eerdere bekende functies van Carolyn Finkle
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| APPLIED MOLECULAR TRANSPORT INC. | Algemeen Adviseur | 14-03-2022 | 27-12-2023 |
Medicago, Inc.
 Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Operationeel Directeur | 01-01-2019 | 01-01-2021 |
| Algemeen Adviseur | 01-01-2019 | 01-01-2021 | |
| PRECIGEN, INC. | Algemeen Adviseur | - | - |
| KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | - | - |
| IMUNON, INC. | Algemeen Adviseur | - | - |
Opleiding van Carolyn Finkle
| University of Ottawa | Undergraduate Degree |
| University of Toronto | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Canada | 4 |
Operationeel
| General Counsel | 4 |
| Corporate Officer/Principal | 1 |
| Chief Operating Officer | 1 |
Sectoraal
| Health Technology | 6 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| IMUNON, INC. | Health Technology |
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| APPLIED MOLECULAR TRANSPORT INC. | Health Technology |
| PRECIGEN, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Health Technology |
- Beurs
- Insiders
- Carolyn Finkle
- Ervaring